Evidence map›Paper›PMID 39501036›Full record

ArticleNature neuroscience2024

Cell type mapping reveals tissue niches and interactions in subcortical multiple sclerosis lesions.

Celia Lerma-Martin, Pau Badia-I-Mompel, Ricardo O Ramirez Flores, Patricia Sekol, Philipp S L Schäfer, Christian J Riedl, Annika Hofmann, Thomas Thäwel, Florian Wünnemann, Miguel A Ibarra-Arellano and 7 more

Abstract read
In one paragraph

Article in Nature neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Neuroglial P2YJournal of neuroinflammation · 2026
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Astrocyte Functional Heterogeneity in Multiple Sclerosis.Journal of clinical neurology (Seoul, Korea) · 2026
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Celia Lerma-Martin *Department of Neurology, Division of Neuroimmunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0000-0003-4201-0816
Pau Badia-I-Mompel *Institute for Computational Biomedicine, Faculty of Medicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-1004-3923
Ricardo O Ramirez FloresInstitute for Computational Biomedicine, Faculty of Medicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-0087-371X
Patricia SekolDepartment of Neurology, Division of Neuroimmunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID http://orcid.org/0000-0001-5776-5272
Philipp S L SchäferInstitute for Computational Biomedicine, Faculty of Medicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0009-0008-4403-8592
Christian J RiedlDepartment of Neurology, Division of Neuropathology and Neurochemistry, Medical University of Vienna, Vienna, Austria.
Annika HofmannDepartment of Neurology, Division of Neuroimmunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Thomas ThäwelDepartment of Neurology, Division of Neuroimmunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Florian WünnemannInstitute for Computational Biomedicine, Faculty of Medicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.
Miguel A Ibarra-ArellanoInstitute for Computational Biomedicine, Faculty of Medicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0000-0001-8411-4854
Tim TrobischDepartment of Neurology, Division of Neuroimmunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Philipp EiseleDepartment of Neurology, Division of Neuroimmunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Denis SchapiroInstitute for Computational Biomedicine, Faculty of Medicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-9391-5722
Maximilian HaeusslerGenomics Institute, University of California Santa Cruz, Santa Cruz, CA, USA.
Simon HametnerDepartment of Neurology, Division of Neuropathology and Neurochemistry, Medical University of Vienna, Vienna, Austria.
Julio Saez-RodriguezInstitute for Computational Biomedicine, Faculty of Medicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany. pub.saez@uni-heidelberg.de.ORCID http://orcid.org/0000-0002-8552-8976
Lucas SchirmerDepartment of Neurology, Division of Neuroimmunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. lucas.schirmer@medma.uni-heidelberg.de.ORCID http://orcid.org/0000-0001-7142-4116

Funding

The UCSC Genome BrowserU24HG002371 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Maximilian Haeussler · 2022 to 2026
$17.6M
Deep Gray Matter Iron and Disease Progression in Multiple SclerosisR01NS114227 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SCHWESER, FERDINAND · 2021 to 2024
$1.5M
A visualization interface for BRAIN single cell data, integrating transcriptomics, epigenomics and spatial assaysRF1MH132662 · NIMH · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI HAEUSSLER, MAXIMILIAN · 2023 to 2023
$866k
California Institute for Regenerative Medicine (CIRM) DISC0-14514Deutsche Forschungsgemeinschaft (German Research Foundation) SPP 2395Deutsche Forschungsgemeinschaft (German Research Foundation) SPP 2395, SCHI 1330/2-1, 4-1, and 11-1EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) ERC StG, No 950584Gemeinnützige Hertie-Stiftung (Hertie Foundation) P1180016National Multiple Sclerosis Society (National MS Society) PA-2002-36405National Multiple Sclerosis Society (National MS Society) PA-2002-36405, RFA-2203-39300NHGRI NIH HHS U24 HG002371NIMH NIH HHS RF1 MH132662NINDS NIH HHS R01 NS114227U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI) U24HG002371U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) RF1MH132662U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS114227
6 · The paper itself

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system. Inflammation is gradually compartmentalized and restricted to specific tissue niches such as the lesion rim. However, the precise cell type composition of such niches, their interactions and changes between chronic active and inactive stages are incompletely understood. We used single-nucleus and spatial transcriptomics from subcortical MS and corresponding control tissues to map cell types and associated pathways to lesion and nonlesion areas. We identified niches such as perivascular spaces, the inflamed lesion rim or the lesion core that are associated with the glial scar and a cilia-forming astrocyte subtype. Focusing on the inflamed rim of chronic active lesions, we uncovered cell-cell communication events between myeloid, endothelial and glial cell types. Our results provide insight into the cellular composition, multicellular programs and intercellular communication in tissue niches along the conversion from a homeostatic to a dysfunctional state underlying lesion progression in MS.

Indexed as

Multiple SclerosisAdultAstrocytesBrainCell CommunicationEndothelial CellsFemaleHumansMaleMiddle AgedNeurogliaTranscriptome

Identifiers

PMID39501036
PMCPMC11614744

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.